FORMATION AND FUNCTIONAL SIGNIFICANCE OF A MOLECULAR COMPLEX DERIVED FROM THE SECOND AND THE FOURTH COMPONENT OF HUMAN COMPLEMENT by Müller-Eberhard, Hans J. et al.
FORMATION AND FUNCTIONAL SIGNIFICANCE OF A MOLECULAR 
COMPLEX DERIVED FROM THE SECOND AND THE FOURTH 
COMPONENT  OF HUMAN  COMPLEMENT*, 
BY  HANS  J.  MOLLER-EBERHARD, M.D., MARGARET J.  POLLEY, PH.D., 
MARY ANN CALCOTT 
(From tie Department of Experimental Pathology, Scripps Clinic and Researck 
Foundation, La Yoga, California) 
(Received for publication 18 October 1966) 
Studies on the mechanism of immune cytolysis have been greatly facifitated 
by the use  of highly purified complement components.  Paradoxically much 
can be learned about immune cytolysis by studying the reactions of comple- 
ment components in solutions which are entirely devoid of cells.  The experi- 
ments described in the present paper were performed to explore the molecular 
interactions  between  the  first  four  components  of  human  complement  in 
cell- and antibody-free solution. Use was made of highly purified preparations 
of the esterase moiety of the first component (C'1),  and of the second (C'2), 
third (C'3), and fourth (C'4) component. It was found that C'2 and C'4 tend 
to interact in free solution to form a reversible protein-protein complex which 
is converted into a stable complex by the action of C'I esterase. Formation of 
the esterase-induced complex results in the generation of an enzyme-like ac- 
tivity which causes the conversion of CP3 to its hemolytically inactive product, 
Cr3i  (1).  Evidence will be presented indicating  that  the  complex is  formed 
not only in cell-free solution, but also on the surface of cells and that it fulfills 
an essential function in cell membrane damage by complement. 
Materials and Methods 
Purified Human Complement Fa~tors.--The esterase moiety of the first component of com- 
plement (2) was isolated and kindly provided by Dr. Irwin Lepow, Cleveland, Ohio. 
The second component was purified from the hydrazine-trested pseudoglobniin fraction 
of human serum by a three step procedure  which  will be described  in detail elsewhere.  1 Briefly, 
the first step consists of chromatography  on citrboxymethyl-ceUniose  using phosphate buffer, 
pH 6.0, ionic strength 0.05 containing  0.0025 ~ EDTA. The protein is eluted by an increasing 
* This is publication No. 190 from the Department of Experimental Pathology, Scripps 
Clinic and Research Foundstion, La Jolls. 
$ This work was supported by United States Public Health Service  Grant 7007-0l and by 
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sodium chloride concentration gradient. In the second step the portion of the chromatogram 
which contains C'2 activity is further separated by preparative electrophoresis on a Pevikon 
block using the same buffer as above. At the conclusion of this step, C'2 is approximately 
5000-fold purified and remains contaminated primarily with  fl~x-globulin.  As revea3ed  by 
starch gel electrophoresis, C'2 represents approximately 30% of the protein of this material 
Most experiments were carried out with "post-Pevikon block C'2." In a  few instances the 
product of the third and final purification step was used which involves either chromatography 
on TEAE,  cellulose or Sephadex filtration. 
The third and the fourth components of complement were prepared according to standard 
procedures which were described previously (3, 4). 
Chemically and En~.ymal~ally Modified Complement Coraponents.---Oxidation of  C'2 was 
carried out by treating the purified component at a  protein concentration not exceeding 1 
mg/ml with an equal volume of 10  -4 g  12 in 5 X  10  -~ u  KI at pH 6 and 0°C for 5 rain. Oxi- 
dized C'2 is 7-10 times as active as untreated human C'2. The method of oxidation has been 
described briefly (5); the evidence that the enhancing effect of iodine is due to oxidation and 
not due to iodination will be presented elsewhere,  t 
C'3 was labeled with radioactive lmI or x25I using the chloramine T  method, as described 
earlier (1, 6). The hemolytic activity of the labeled protein was unimpaired, its specific radio- 
activity  was  approximately  50,000  cpm//zg. 
To obtain C'4i (monomer), C'4 was treated with C'1 esterase as outlined previously (7). 
The C'1 esterase treated, hemolyticaily inactive C~4 was then subjected to sucrose density 
gradient ultracentrifugation to separate C'4i-aggregates (12S-14S)  from C'4i monomer (8.9S). 
Alternatively, the monomeric form of C'4i was isolated by gel filtration using Sephadex G-200 
equilibrated with phosphate buffer, pH 6.0, ionic strength 0.15. The aggregates appear in the 
exclusion volume, while the monomer is retarded.  Fractions containing the monomer were 
pooled, dialyzed against veronai buffer, pH 7.3, and concentrated by ultrafiltration to a pro- 
rein concentration of 1-4 mg/ml. 
Dete~gon and ~ntitatdon of C 3 Conversion.--Conversion of C'3 to C'3i is readily detected 
by immunoelectrophoresis. It was quantitated using radioactively labeled C'3.  Conversion 
was stopped by cooling the reaction mixtures to 0°C. Subsequent separation of C'3 and Ct3i 
and quantitative evaluation were described earlier (1). 
Detection and Esgmation of CZ Activity.--This  was done either using the classical serum 
reagent, R2  (8), or utilizing the conversion of EACqa,4 cells to  EAC'la,4,2a by C~2. The 
former were prepared as described earlier (1) and the latter were assayed using EDTA serum 
(8). 
Preparation of C3-Converting Activity  in Cell- and Antibody-Free Solution:  (C'44,g)a.-- 
20 #g of C'2 or of iodine-treated Ct2 was mixed with 200 #g of C'4. Usually phosphate buffer 
of pH  6.5--7.5  and ionic strength 0.15 was used which contained 1.5  m~ Mg  ++. The total 
reaction volume was 0.5 ml. After the temperature was adjusted to 32°C, 0.5 units of purified 
C'I esterase was added. The reaction was allowed to proceed for 10 rain at 32°C when the 
complex was made with iodine-treated C'2 and for 2 rain when untreated C'2 was employed. 
The material was then utilized immediately or stored at 0-2°C.  (C'41, 2)a made with iodine- 
treated C'2 retained C'3 converting activity for several days when stored in the refrigerator. 
Preparation  of  Sheep-Erythrocyte-Complement Complexes.--EC'4,  the  erythrocy'te-C'4 
complex, was prepared as described previously (7). 
EC'4, °Xy2a,  erythrocytes carrying on their surface only the activated complex of C'4 and 
oxidized C'2, were prepared in the following maamer. 2 ml of a  7.5% suspension of EC'4 in 
veronal buffer, pH  7.3,  containing Ca  ++ and Mg  ++ was placed at 32°C.  0.4 ml of purified, 
iodine-treated C'2 was added which was followed after 2  rain by addition of 0.25 units of 
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was 20  rain. The ceils were washed  twice with ice-cold verona]  buffer, their concentration 
adjusted to 2.5%, and they were then stored at 2°C until used. They were lyzed by incubation 
at 32°C with human serum, 1:40, in the presence of 0.01 ~ Na3EDTA. 
Sucrose Density  Gradient  Ultracen~rifugaffon.--Linear sucrose density gradients  (7-31%) 
were produced with the Buchler automatic density gradient device. Sucrose solutions were 
made up in phosphate buffer of ionic strength and pH indicated below. Ultracentrifugation 
was performed for 20 hr at 35,000 rpm and 4°C in a Spinco L-2 machine employing an SW39 
rotor.  Fractions were obtained using the Buchler gradient fractionation device. For s  rate 
determinations  the  following  reference  substances  were  used:  l~SI-labeled  thyroglobulin 
(195),  125I-labeled "yG-globulin  (75),  and hemoglobin (4.55). 
Gel Filtration.--A 100  X  2 cm column, Sephadex G-200 and phosphate buffer, pH 6.0, 
ionic strength 0.15 were used. The length of the gel bed was 80 era. For application the density 
of the sample was raised by addition of NaC1 and the sample was layered between the gel bed 
and the supernatant  buffer. 1-2 ml fractions were collected. For the determination of diffu- 
sion coeffLcients, the above reference substances were employed, thyroglobulin (2.5  ×  10  -~ 
cm~/sec), "yG-globulin (3.8 X  10  -~ cm~/sec), and hemoglobin (6.8 X  10  -7 canS/see). The diffu- 
sion coe~eient of C'2 was also determined in veronal buffer, pH 7.4, ionic strength 0.15, con- 
taining 0.005  ~  NasEDTA. 
Quantitation of Formation and Decay of (C'4/,2)a.--Two different reaction mixtures were 
prepared, both containing 80 ttg of C'4, 1.5 m~ Mg  ++ and 0.05 units C'1 esterase in isotonic 
veronal-NaC1 buffer, pH 7.3. One contained, in addition, 20 ttg of iodine-treated C'2 and the 
other 100 ttg of untreated C'2. C'1 esterase was added last after the temperature of the solu- 
tions had been adjusted to 35°C. The total reaction volume was 0.5 ml and 0.05 ml samples 
were withdrawn at indicated intervals of time after the reaction was triggered by addition of 
C'I esterase. The samples were pipetted into ice-cold tubes containing 10/A of 0.1 ~x EDTA. 
After all samples were collected, they were assayed for C'3-eonverting activity as described 
above. 
Nomeuclature.--The  complement nomenclature used in this publication conforms with the 
recommendations of the active members of the Complement Workshops held in Bethesda, 
1963 (9) and in La Jolla, 1966  (10).  Individual complement components are designated nu- 
merically. Erythrocyte (E)-antibody (A)-complement (C') complexes are denoted systemati- 
cally according to their composition or according to the reaction step they have completed; 
e.g., EAC'I, EAC'I,4, EAC'1,4,2, etc. Since C'1 and  C'2 have to undergo activation (a) 
before they become hemolytically effective, these complexes are more accurately referred to 
as EAC'la, EAC'la,4, EAC'la, 4, 2a. After inactivation by C'I esterase C'2 is called C'2i (11). 
To convey the results of recent studies undertaken in this laboratory, the following addi- 
tional symbols and terms will be used in the present and in subsequent publications. They are 
constructed in accordance with the general rules for complement nomenclature. 
C'4i: C'I esterase-trcated C'4 which has undergone characteristic physicochemlcal changes 
and has lost the capacity to become bound to groups which serve as C'4 receptors. 
C'3i: C'3 convertase (see below)-treated C'3 which has undergone characteristic chemical 
changes and which has lost the capacity to become bound to groups which serve as C'3 re- 
ceptors. 
°~YC~2:C'2 oxidized by treatment with a critical concentration of iodine, a measure which 
results in a  10-fold enhancement of its hemolytic activity. 
Ct4,2." Reversible protein-protein complex of hemolytically active C'2 and C~4; complex is 
devoid of C~3 convert~e activity. 
C'4i,2: Reversible protein-protein complex of C~4i and C'2; devoid of C'3 convertase ac- 
tivity. 
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in the presence of Mg++; possessing capacity to convert C'3 to C'3i and to induce hemolysis 
from the fluid phase with low efficiency; once formed the complex is incapable of becoming 
bound to receptor groups owing to the effect of C'I esterase on its C'4-derived subunit. 
C'4,ga: Receptor-bound  complex possessing C'3-converting activity;  exhibiting  high 
cytolytic efficiency  if bound to cell surface receptors. 
C'3 convcrtase: Trivial name for the fluid phase complex, (C'4i, 2)a, and the receptor-bound 
complex, C'4,2a; referring to its enzymatic effect on Ct3. 
RESULTS 
Which Complement Components  are Required for the Generation of C'3-Con- 
vetting Activity in Cell-Free Solution?  As described previously (1), conversion 
of C'3 to C'3i is accompanied by loss of hemolytic activity and by characteristic 
TABLE I 
G~w~n ~ C'3-ConvwtingAa~y~Fr~ SoluHon 
Components  Ct3-convertlng activity 
C'I esterase 
Cq esterase, C~4 
C'I esterase, Cr2 
C'I esterase, C'4, C'2 
C'I esterase, C'4 (30', 370C), C'2 
C'I esterase, C'2 (30', 37°C), C'4 
Negative 
Negative 
Negative 
Positive 
Positive 
Negative 
Conditions: C'I esterase, 0.5 unit; C'2, approximately 1/zg; C'4, 1 #g; Ct3, 180 ~tg; total 
volume, 0.15 ml; time at 37°C, 20 min. 
physicochemical  and  immunochemical  changes  of  this  protein.  Conversion 
is a necessary part of the mechanism of binding of C'3 to cells and is mediated 
only by those  cells  which  contain  the  activated  second component on  their 
surface.  The  kinetics  and  the  conditions  of  the  conversion  have  suggested 
that it is an enzymatic reaction. 
To study the manner in which  C'3-converting activity is generated and to 
identify its physicochemical correlate, the following experiments were carried 
out.  Small amounts  of highly purified  C'I esterase  (0.5  unit),  C'2  (approxi- 
mately 1 #g),  and  C'4  (1  gg)  were  incubated  in  various  combinations  with 
180 ~tg of C'3 in Mg++-containing buffer. After 20 rain at 37°C the reaction 
mixtures  were  analyzed  for  C'3i.  The  results  are  summarized  in  Table  I. 
C'3-converting activity was generated neither when C'2 nor C'4 were treated 
with C'1 esterase. It was generated, however, when a solution containing both 
C'2 and C'4 was subjected to the action of the enzyme. The activity also ap- 
peared when  C'4 was first incubated  alone  with  C'I esterase and  when  C'2 
was added  to this mixture 30 min later.  When  the sequence of addition  was H. ~. M-ULLER-EBERH.ARD, M. J.  POLLEY, M. A. CALCOTT  363 
reversed,  i.e.  when incubation of C'2 with the enzyme preceded  addition of 
C'4,  C'3-converting  activity failed to be generated.  Furthermore, formation 
of the activity was inhibited by 0.01 ~  EDTA. This effect could be overcome 
by addition of Mg ions. 
These observations indicated that both C'2 and C'4 were required for induc- 
tion of C'3-converting activity.  They further indicated that C'2 was inactivated 
when treated with the esterase  in the absence  of C'4,whereas  C'4 retained 
its activity in the  free  solution  system after treatment with esterase in the 
absence of C'2. It waspostulated, therefore, that C'4 serves as an acceptor  for 
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FIG.  1.  Quantitative relation between the degree of conversion of C'3 and the amount of 
C'I esterase present in the reaction mixture. The reaction was carried out for 30 min at 37°C 
in veronal buffer, pH 7.4,  ionic strength 0.15. The total volume was 0.2 ml and contained 
0.5 pg °xYc'2, 5 ptg C'4, and 1.5 mm Mg  ++. 
esterase-modified  C'2  and that C'3-converting  activity resides in an esterase 
induced complex of C'2 and C'4. 
Quanlitative Relation Between C'3-Converting Aai~ity  and  the Complement 
Components Required for its Generation.--To gain insight into the mode of 
action of C'3-converting  activity, conversion was studied as a function of the 
concentration of C'1 esterase,  C'2,  and C'4.  In these experiments  two of the 
components were supplied in optimal concentration while the amount of the 
third was varied. Each reaction mixture contained 160 #g of C'3-181I and the 
reaction was allowed to proceed for 30 rain at 37°C, whereupon the amount of 
C'3i-mI produced during the incubation period  was determined.  The results 
are demonstrated in Figs. 1-3, which show the relation between the degree of 
conversion and the concentrations of C'1 esterase,  C'2, and C'4, respectively. 
The concentration of C'2 was recorded in relative values since the preparation 364  MOLECULAR  COMPLEX  FROH  HUMAN  COMPLEMENTS 
used  was  contaminated with  iliA-globulin, C'2  representing  approximately 
one-third of the protein content of this material.  On the basis of these deter- 
minations the etficiency of the three components  could be calculated.  It was 
found that, in the presence of optimal amounts of the other two components 
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FIO.  2.  Quantitative relation between  C'3  conversion and  the relative amount  of  C'2 
in the reaction mixture. The reaction was carried out for 30 rain at 37°C in veronal buffer, 
pH 7.4,  ionic strength 0.15,  containing 1.5 mE Mg  ++,  0.5  unit C'1 esterase and 5/zg  C'4. 
The total volume was 0.2 nil. In absolute terms the concentration of C'2 ranged approximately 
from 0.025 to 0.25 #g protein. C'2 was iodine treated. 
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FIG. 3.  Quantitative relation between C'3 conversion and the amount of C'4 in the reac- 
tion mixture. The reaction was carried out for 30 rain at 37°(] in veronal buffer, pH 7.4, ionic 
strength 0.15, and in the presence of 0.5 unit C'1 esterase, 0.5 #g °xyc'2 and 1.5 mM Mg  ++. 
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and under the selected experimental conditions, 10,000 #g of Ct3 can be con- 
verted by 1.25 units of C'1 esterase,  12.5 ~g of C~2, and 2.5 #g of C'4. The 
quantitative relations indicate that these components function as a catalyst in 
the conversion reaction. The trivial name C'3 convertase will be used in the 
following to denote the active principle. 
Coraparatlve Ultracentrifugal and Gel Filtration Studies  of C'3 Convertase and 
its  Precursors.--Experiments  described  above  had  suggested  that  C'3  con- 
vertase might constitute a protein-protein complex which is derived from C'2 
and C'4. An ultracentrifugal analysis was therefore performed to compare the 
sedimentation velocity of C'3 convertase with that of its precursor components. 
2O- 
"~ t5_  "" 
5- 
19S 
t 
i  5  1'0  1"5 
C'3 Convertase 
MOn°mer) 
\ 
2'O  2"5  3"O 
Fraction Humber 
2O 
N.I -~ .10~ 
Fro. 4.  Comparative ultracentrifugal analysis of C'3 convertase and one of its precursors, 
C'JA; performed in a 7-31% sucrose density  gradient in phosphate buffer, pH 6.0, ionic strength 
0.15; for 20 hr at 35,000 rpm  As reference substances were used, 19S:thyroglobulin; 7S:'yG- 
globulin; and 4.5S: hemoglobin. 
The  convertase  was  prepared  from the  monomeric form of highly purified 
Ct4i and from partially purified C"2 by treatment with Ctl esterase in the pres- 
ence of Mg  ++. Usually the mixture was held for 5 rain at 37°C before it was 
rapidly cooled to IoC and subjected to ultracentrifugation in a sucrose density 
gradient. All initial attempts to recover Ct3 convertase activity from gradient 
fractions failed. As will be seen below, the activity is exceedingly labile at 35°C. 
Although ultracentrifugation was  carried out at 3-5°C, the failure to recover 
activity could be attributed to its decay during the 20 hr period of centrifuga- 
tion. 
Recovery difficulties were overcome when it was found that prior oxidation 
of C'2 with a critical dose of iodine (5) resulted in a much greater stability of 
the  convertase.  Accordingly,  in  all  subsequent  ultracentrifuge experiments 
C'2 was employed in its oxidized form. Fig. 4  depicts the result of a  typical 
experiment and shows that  C~3 convertase activity sediments more rapidly 
than C~4i, which in other experiments was found to be heavier than C'2 (see 
below).  Using  three  reference proteins  of known s  rates,  the sedimentation 366  ~OLECULAR  COMPLEX I~ROM HUMAN  COM~PLEMENTS 
velocities of C'3 convertase, C'4i,  and  Ct2 were determined and found to be 
11.2S, 8.9S, and 5.5S, respectively (Fig. 5). The former two values were arrived 
at by duplicate determination, the latter represents the mean of ten separate 
determinations. 
The monomeric form of C'4i was used in these experiments in preference to 
native C'4. When C'4 is converted by C'I esterase to C'4i, 30-50 % of the pro- 
tein forms aggregates which have an s  rate of 12S-14S  (7). By working with 
preformed C'4i monomer, it was possible to rule out that the aggregates were 
responsible for the sedimentation behavior of C'3 convertase. 
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FIG. 5. Determination of the sedimentation coefficients  of CP3 convertase and of C'4i 
after ultracentrifugation  in a linear sucrose  density gradient in the presence  of three reference 
substances. The data were derived from two separate experiments. 
To obtain appro×imate values of the diffusion coefficients (D) of C'3 convertase 
and its precursors,  the method of Andrews  (12)  was employed. A  sample of 
the same mixture of substances which was used to obtain the ultracentrifuge 
pattern depicted in Fig. 4  was subjected to gel filtration on Sephadex G-200. 
The  result  (Fig.  6)  shows  that  the  sequence  of elution of these substances 
closely reflects their sedimentation behavior, C'3 convertase emerging earlier 
from the column than C'4i and C'2. Using three reference proteins with known 
diffusion coefficients, the diffusion coefficients of C'3 convertase, C'4i and C'2 
were estimated and found to be 3.3, 3.5, and 4.3  ×  10  -7 cm  z sec, respectively 
(Fig.  7). The values for C'4i and C'2 represent the  mean  of  two  determina- 
tions. The second gel filtration experiment with C'2 was carried out using par- 
tially purified C'2  and isotonic  veronal  buffer,  pH  7.4,  containing 0.005 
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Utilizing the above recorded values for s and D, the molecular weights were 
calculated and,  with  the  aid of a  nomogram  for molecular parameters  (13), 
the corresponding frictional ratios were estimated. The partial specific volumes 
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FIG. 6.  Elution diagram of C'3 convertase and its precursors,  C~2 and C'4i, obtained after 
gel filtration on a Sephadex G-200 column  (2 X  80 cm). The column was equilibrated with 
phosphate buffer, pH 6.0, ionic strength 0.15. The sample volume was 1.0 ml and also con- 
rained three reference substances. 
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FIG. 7.  Estimation of the diffusion coefficients of C'3 convertase and of its precursors, 
C'2 and C'4i. Elution volumes for gel filtration on a Sephadex G-200 column (see Fig. 6) are 
plotted against the reciprocal  of the diffusion coeflicientsaccording to Andrews (12). The diffu- 
sion coefficients of three reference substances are:thyroglobulin, 2.5 X  10-Tcm2/sec; ~/G-glob- 
ulin, 3.8 X  10  -7 cm2/sec; and hemoglobin, 6.8 X  10  -7 cm2/sec. 
were assumed to be 0.73;  this being the value for C'3 which was ascertained 
on  the  basis of the  amino  acid composition of this protein? The  results are 
summarized  in  Table  II.  The  molecular weight  of  C'3  convertase,  although 
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considerably larger than that of C'4i and of C'2, appears to be by 39,000 smaller 
than the sum of the molecular weights of these two precursors. 
TABLE II 
Molecular Parameters of C~3 Convertase and its Precursors 
Component  s  D  f/fo  gol wt 
C'3 convertase  11.2  3.3  1.48  305,000 
C'4i (monomer)  8.9  3.5  1.50  229,000 
C/2  5.5  4.3  1.50  115,000 
s, sedimentation coefficient; D, diffusion coefficient; and f/fo, frictional ratio. 
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FIG. 8.  Demonstration of reversible interaction between purified  C'2 and purified C'4 
upon ultraeentrifugation in a 7-31% sucrose density gradient. Samples of identical  composition 
were applied to the three gradient tubes, each containing 180/Jg C'4 and less than 5/zg nxYC~2 
in a total volume of 0.2 ml. Phosphate buffer, ionic strength 0.15, and of indicated pH was 
present throughout the sucrose gradient. Ultracentrifugation was performed for 20 hr at 
35,000 rpm. Direction of sedimentation was toward the left. As marker was used C~3-125I, 
which is not shown in the diagrams. C'2 was localized by hemolytic assay, C'4 by protein de- 
termination. 
Reversible Interaction of the Second and Fourth Components of Complement in 
the Absence of C'I  Esterase.--In control experiments it was  found  that Ct2  is 
capable of interacting with C'4 and  C/4i even in the absence of Ctl  esterase. 
The  resulting protein-protein complex differs from  C~3  convertase  in  that  it 
has a  greater sedimentation rate, is reversible and lacks Ct3-converting activ- 
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The  conclusions were  derived from the  following observations.  When ex- 
amined by density gradient ultracentrifugation, purified C'2 sediments at a 
rate of 5.4S-5.7S. In mixtures with purified C'4, in which the concentration of 
C'4 is large as compared to that of C'2, C'2 sediments appreciably faster, its 
s rate varying with the ionic strength and pH of the buffer. The phenomenon 
is illustrated in Fig. 8, which shows the ultracentrifugal behavior in mixtures 
with C'4 at pH S, 6, and 7. With increasing pH the sedimentation velocity of 
C'2 becomes greater, while that of the C'4 peak remain.q unchanged. A similar 
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FIG. 9.  Plot of sedimentation rates obtained by sucrose density gradient ultracentrifugation 
against pH, for C~2 alone, C~4 alone, and for C~2 in mixtures with CI4 where the concentration 
of C~4 was large compared to that of C'2. C'3-1~5I (9.5S) was used as reference substance for 
s-rate calculations. 
pH-dependent variation in s rate was not observed when C~2 was analyzed in 
the absence of C'4. 
The results of several experiments show (Fig. 9) that in mixtures of C'2 and 
C'4, the s rate of C'2 varies from 7.7S at pH S to 13.5S at pH 8. Under the 
conditions employed there appears to exist a linear relation between s rate and 
pH.  Evidently, at neutral and alkaline pH the interaction between C~2 and 
C'4 results in the formation of a  relatively stable complex which sediments 
ahead of the zone of free Ct4. At pH 5, interaction is minimal causing C'2 to 
trail behind the C'4 zone, but at a  rate greater than that of C'2 sedimenting 
independently. At pH 6 and 6.5 the interaction causes C'2 to sediment at an 
intermediate rate and within the C~4 zone. 
Similar results were obtained using C'4i-monomer (Fig.  10).  The s  rate of 
the C'4i, 2 complex was smaller than that found for the C'4,2 complex at com- 
parable environmental conditions. This is, most probably, due to the s  rate 12' 
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difference between C'4 and C'4i (7). Both the C'4,2- and the C'4i, 2-complex 
are completely devoid of C'3-converting activity. 
The effect of ionic strength is recorded in Fig. 11, which shows that the sta- 
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Fzo. 10. Plot of sedimentation  rates against pH. Analysis  by sucrose  density gradient ultra- 
centrifugation of C'4i alone and of C'2 in mixtures with C'4i where the concentration of C'4i 
is large compared to that of C'2. For comparison, data on the ultracentrifugal behavior of 
C'3 convertase are included. 
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Fzo. Ii. Sedimentation  rate  of  Cr2  in  mixtures with C'4  as  a function  of  conductance. The 
concentration  of  C'4  was large  as  compared to that  of  C'2.  Uhracentrifugation was performed 
in sucrose  density  gradients. 
bility of the complex is inversely proportional to the conductance of the buffer. 
The presence of 0.005 ~r NasEDTA throughout the sucrose density gradient 
resulted in weakening of the C'2-C'4 interaction but not in its complete inhi- 
bition.  It is  emphasized that  almost all  experiments were carried out  using 
phosphate buffers. In a single experiment, isotonic veronal buffer, pH 7.4, was 
employed.  In  this  case,  C'2-Ct4  interaction appeared  to  be  completely in- 
hibited by 0.005 ~  NasEDTA and promoted by bivalent cations. H.  J.  M0LLER-EBE,  RHARD,  M.  J.  POLLEY,  M.  A.  CALCOTT  371 
Preliminary results indicate that a  similar interaction can also be demon- 
strated in whole human serum at ionic strength 0.1 or 0.05 in phosphate buffer. 
After  density gradient ultracentrifugation,  C~2  was  found to  be  distributed 
bimodally, the two activity peaks corresponding to s  rates of approximately 
6S and 9S-12S, respectively. 
Speed of Formation and Stability  of C'3 Convertase Actlmty.--As mentioned 
above, the use of °*YC'2 in the formation of C'3 convertase resulted in a much 
greater stability of the activity. To compare the chemically modified and the 
unmodified complex, their formation and decay was studied as a  function of 
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FIG. 12. Formation and decay of C'3 convertase. Activity and stability of C'3 convertase 
at 35°C are greatly enh.nced when it is derived from °xYC'2 (upper curve). The lower curve 
was obtained with C'3 eonvertase  derived from unmodified C'2. The latter was used at 5 times 
the concentration (cone.) of °*YC'2. 
time. Two reaction mixtures were prepared which were identical with respect 
to the concentrations of C~I esterase, C~4, and Mg  ++. One contained a  given 
amount  of °=YCI2 and  the  other five times  this  amount  of unmodified C'2. 
Esterase was added last to the reaction mixtures and the time of addition was 
defined as  zero  time.  Samples  were  withdrawn  after  certain  intervals  and 
pipetted into a solution of EDTA, thus stopping the process of C'3 convertase 
formation.  Simultaneously,  the  temperature  of  the  withdrawn  sample  was 
lowered to 0°C to prevent decay of the generated activity. At the end of the 
experiment, C"3 convertase activity was assayed in all samples using C'3-m~I. 
The results are shown in Fig.  12. Three facts are evident. First, formation of 
convertase at 35°C proceeds rapidly. Second, the complex containing °=~C'2 is 
several times as active as the complex prepared with unmodified C'2. Third, 
the activity of the complex derived from °*YC'2 is of greater stability, its half- 372  MOLECULAR  COMPLEX  FROM  HUMAN  COMPLE]~IENTS 
life at 35°C being approximately 200 rain as compared to a  half-life of approxi- 
mately 17 min for convertase derived from unmodified C'2. 
Assembly of C3 Convcrtase on the Erythrocyte  Surface and its Significance in 
Immune  ttemolysis.--Having  shown  that  the  (Cr4i,2)a  complex  possesses 
C'3-converting  activity,  the  question  arose  as  to  whether  this  complex  is 
functionally significant in  immune cytolysis. The occurrence of a  cell-bound 
form of the  complex appeared probable in  view of the  previous finding  (1) 
that  conversion  is  a  necessary event  in  the  process  of  binding  of  Ct3  to 
EACqa, 4,2a cells.  Since direct physicochemical demonstration of cell-bound 
I00 - 
8 
oc0  80-  No 
--"  60- 
.<2_ ._~ 
~.  ~  40- 
~  20- 
C'2  1:200  (iodine) 
C'I esterose, 0.54 units/ml 
~ 
L 
i  i  i  J  i  J  i  ,  /  / 
5  I0  4~3 
'Minutes at 37°C 
FIO. 13. Formation of erythrocyte-C'4,2a complexes  as a function of time. EC'4 cells were 
treated with °xyct2 and Ctl  esterase. 
C'4,2a is presently not feasible, it was attempted to assemble the complex on 
the surface of erythrocytes utilizing essentially the  same  method which  was 
employed for its formation in cell-flee solution. 
The procedure consists of two steps. First, C'4 was treated with C'I esterase 
in the presence of nonsensitized sheep erythrocytes (E). This step,  as shown 
previously (7), leads  to formation of erythrocyte-C'4 complexes (EC'4).  The 
cells were washed to remove fluid phase Ct4i which otherwise would later com- 
pete  with  bound  C'4 for free C'2.  During  the  second step,  EC'4  cells  were 
treated with °*YC'2, Mg  ~- and C'I esterase. After 5-20 min at 37°C, the cells 
were washed and analyzed. 
Analysis of the resulting product revealed two facts. First, the cells possessed 
membrane-bound C'3-converting activity and the ability to bind C'3  (1). As 
they lacked antibody and  Cq  because  neither of which  was  supplied,  they 
may be systematically described as  ECt4,2a.  Second, the cells were readily 
]ysed by EDTA-serum which supplies  C'3,  5,  6,  7,  8,  and 9,  but not C'I,  2, 
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The appearance of  C'3-converting activity may be considered indicative of 
successful assembly of the C'4,2a complex on the surface of these cells.  Their 
undergoing  lysis  in  the  presence  of  EDTA-serum  demonstrates  clearly that 
the  complex  thus  assembled is  hemolytically active.  Formation  of  EC'4,2a 
from EC'4 and C'2 is shown in Fig.  13 as a function of time at 37°C. 
Induction of Hemolysis by Fluid Phase C'3 Convertase.--Ordinarily  C'3  con- 
vertase is cytolytically effective only when bound to cells.  However, in excep- 
tional circumstances cytolysis can be induced  by fluid phase  C'3 convertase, 
(C'4i, 2)a, although it is incapable of attaching itself to cells.  To demonstrate 
TABLE III 
Induction of Hemolysis by Fluid Phase C'3 Convertase 
Per Cent Lysis of 2 X  l0  s Cells 
Treatment 
EDTA-C' 
EDTA-C' +  (C'4i, 2)a 
EDTA-KSCNC' 
EDTA-KSCNC' +  (C'4i, 2)a 
EDTA-buffer +  (C'4i, 2)a 
Conditions: C' 1:40, EDTA 0.01 M, volume 1 m]  40 rain 
pared with °xYC'2). 
PNHE  Norm. Hum. E. 
0 
28 
0 
40 
at 32°C; (C'4i, 2)a 20 #g (pre- 
Abbreviations:  PNHE,  erythrocytes  from patient  with  paroxysmal  nocturnal  hemo- 
globinuria; Norm.  Hum.  E.,  normal  human  erythrocytes;  and  KSCNC',  human  serum 
treated with 1 M  KSCN. 
the hemolytic activity of fluid phase C'3 convertase erythrocytes from patients 
with paroxysmal nocturnal hemoglobinuria (PNH) were used which are known 
to be particularly susceptible to complement action  (14).  As normal erythro- 
cytes,  these  cells are unaffected by incubation  with EDTA-serum.  However, 
when  (C'4i, 2)a  was  added  which  had  been prepared  with °xYC'2, hemolysis 
ensued.  The  hemolytic  effect  of  (C'4i,2)a  could  not  be  explained  solely  in 
terms of its action on C'3 because hemolysis was also observed when KSCN- 
treated  serum  was  employed which  contained  C'3  in  hemolytically inactive 
form (15).  The results  which  are summarized in Table III indicate that fluid 
phase C'3 convertase exerts its hemolytic effect by acting on C'3 as well as on 
later components of the complement sequence. 
Effect  of C'3  Convertase  on C'3  in  Cell-Free  Solution.--The  action  of  cell- 
bound  C'3  convertase on  C'3 has been shown  to result  in  increased  electro- 
phoretic  mobility,  reduced  sedimentation  velocity,  and  loss  of  at  least  one 
antigenic  determinant.  The  product,  C'3i,  was  hemolytically  inactive.  At 374  MOLECULAR COMPLEX FROM HUMAN COMPLEMENTS 
neutral or alkaline pH,  a  low molecular weight split product could not be de- 
tected after conversion (1).  However, at acid pH a  split product becomes dis- 
sociated from  C'3i,  as  was first pointed out by Lepow.  ~ Fig.  14  shows an im- 
munoelectrophoretic analysis of C'3  after conversion by (C'4i,2)a at  pH  6.0. 
In addition to the main precipitin arc in the a~-globulin region, a  smaller pre- 
cipitin line is visible which fuses with the main arc. It reveals the presence of 
a  rapidly migrating, antigenically deficient fragment of C'3. 
This fragment was investigated further  using 12~I-labeled C'3. After conver- 
FIG. 14.  Demonstration of cleavage of C'3 by C'3 convertase.  The curve was obtained by 
gel filtration on a Biogel P-150 column of C'3-1251 after treatment with (C'4i, 2)a. The column 
was equilibrated with phosphate buffer, pH 5.0, ionic strength 0.15. Component  A emerged 
from  the column  with the exclusion fraction. The position of cytochrome  c  (~  =  12,000), 
which was used as reference substance,  was between component  B and C. Native CP3 gave 
rise to one fraction only which was excluded by the gel. The inserted immunoelectrophorefic 
patterns show C'3 before and after conversion. The pattern of C'3i consists of two precipitin 
lines. That line b merges into line a is interpreted as being due  to incomplete dissociation of 
C'3i under the conditions  employed for immunoelectrophoresis. 
sion at pH 6.0 C'3 was subjected to gel filtration at pH 5.0.  As shown in Fig. 
14,  three 12~I-labeled components emerged from the Biogel P-150 column. The 
major component  comprised more  than  90 %  of the  labeled material and ap- 
peared in the exclusion fraction. Two minor components, representing together 
approximately 8%  of the labeled protein, were retarded. When native C'3-125I 
was analyzed at pH 5 using the same Biogel column, the two minor components 
were  not observed,  instead all the radioactive label appeared in  the  exclusion 
volume. 
Using soybean trypsin inhibitor (M  =  21,500) and cytochrome c (~  --  12,000) 
as  reference  substances,  it  was  estimated that  the  molecular weight  of frac- 
tion  B  is between  12,000  and  21,500,  and  that  of  fraction  C  is  smaller than 
3 I.  It. Lepow.  Personal communication. H. J. ~LLER-EBERHA_RD~  M. J. POLLE¥~ M. A. CALCOTT  375 
12,000. It was noticed that the relative proportions of fractions B and C may 
vary from one experiment to the other. Furthermore, both components tend to 
aggregate upon storage at 4°C. The chemical nature of  the two minor com- 
ponents and their relationship to each other and to the parent  C'3 molecule 
are presently under investigation. 
DISCUSSION 
As  complement represents  a  system of multiple  protein  components,  its 
function may be expected to be based upon protein-protein interactions. In- 
teractions  between  complement  components  were  recently  discovered  and 
studied by physicochemical methods. The first component of complement was 
found to result from the calcium-dependent association of three distinct serum 
proteins,  Cqq,  CPlr,  and Cqs  (16).  Purified Cqq  was shown to  enter into 
reversible, Ca-independent complexes with native ~G- and -yM-globulin (17). 
The fifth, sixth, and seventh components of human complement were recog- 
nized as an interacting protein system (18). The present publication reports of 
yet another example of functionally relevant interactions between complement 
components. The second and the fourth components were found to interact 
with each other in two distinct ways; they form reversible complexes in the 
absence of Cq esterase and in its presence they give rise to a structurally com- 
plex enzyme: C~3 convertase. 
The reversible interaction between C~2 and C'4 is readily demonstrated by 
zone ultracentrifugation. It is dependent upon pH, ionic strength, and other 
environmental factors such as buffer ions. It is facilitated by a relatively high 
concentration of CP4. The variability of the sedimentation velocity of C'2 in 
mixtures with Ct4 may be explained in the following manner. The rate con- 
stants  of  the  reaction  C~2  +  C~4  ~  C~4,2  vary  with  environmental 
conditions. Under conditions which favor dissociation, C~2 is enabled to sedi- 
ment in free form. Conditions that favor association cause C~2 to sediment in 
the complex. Between these two extremes Ct2 may assume a variety of differ- 
ent sedimentation velocities, its actual velocity in a  given experiment being a 
reflection of  the  prevailing  equilibrium position  of  the  interacting  Cr2-Ct4 
system. 
The reversible reaction between C~2 and C~4 is indicative of a functionally 
meanin~ul molecular affinity. These two proteins are precursors of an enzyme 
which is generated through the action of Cq esterase and which assumes, for 
many reasons, a central position in the complement reaction. Since it is acting 
on Ct3, effecting its conversion to C'3i, it was provisionally referred to as C~3 
convertase. The complex structure of the enzyme was inferred from two inde- 
pendent observations. First, both C'2 and CP4 are required for the formation 
of the enzyme. Second, the molecular weight of the active entity is larger than 
the molecular weight of either C'2 or C~4. 376  MOLECULAR  COMPLEX  FROM  R-UMAN  COMPLEMENTS 
Molecular weight determinations yielded values indicating that the Cr3 con- 
vertase molecule is by 39,000  smaller than the sum of one C'2 and one Cr4 
molecule. This finding may be interpreted  in two  different ways.  First,  the 
actual value for Cr3 convertase may be 344,000 instead of 305,000 as measured. 
There is some uncertainty as to the exact diffusion coefficient of the enzyme 
due  to  the  limitation of the  method used for  its  determination.  For larger 
molecules, gel filtration on Sephadex G-200 yields less reliable results. On the 
other hand, the actual molecular weight of C'2 may be smaller than the value 
found in this study. As C'2 enters into a  reversible interaction with Ct4, the 
presence of the latter influences both the  sedimentation and diffusion coeffi- 
cient.  Although measures  were  taken  to  exclude  interference  by  C'4,  it  is 
theoretically conceivable that small amounts of C'4  were present during the 
s and D  determinations on C'2 and that thus the molecular weight determina- 
tion resulted in an erroneously high value. 
The  second  interpretation considers fragmentation of at  least  one  of the 
precursor  molecules as part  of the  mechanism of C'3  convertase formation. 
Instead of the whole molecule, only a fragment thereof becomes incorporated 
into  the  enzyme. While fragmentation of C'4  by C'I  esterase  has  been  ex- 
cluded (7), fragmentation of C~2 is considered possible and has actually been 
postulated by Mayer and associates (20). Presently available information does 
not allow distinction between the two alternative interpretations of the molec- 
ular weight data. 
The  conclusion  that  the  CP3-converting  principle  is  an  enzyme is  based 
essentially on two observations. A given amount of (C'4i, 2)a is able to convert 
within  a  short  period  of  time  several  thousand  times  this  amount  of  C'3. 
Secondly, conversion of C'3 is accompanied by fragmentation of the molecule, 
the fragments being dissociable at acid pH. While it is evident that the natural 
substrate of the enzyme is C'3, it is not known as yet which type of chemical 
bond is attacked. 
The concept of the formation of C'3 convertase that emerged on the basis 
of the present study may be summarized as follows (Fig.  15). Ctl  esterase- 
modified C'4 (C'4i) serves as an acceptor for C'I esterase-modified C'2.  Col- 
lision of the two molecules results in the formation of the complex which is 
endowed with C'3-converting activity. Generation of the enzyme requires Mg 
ions. While the acceptor activity of C'4i is stable, the ability of C'I esterase- 
modified C'2 to combine with C'4i is exceedingly labile.  Unless a  C'2 molecule 
collides with an acceptor molecule immediately following its "activation", it 
will become irreversibly inactivated. "Activation" of C'2 by Ctl esterase may 
involve cleavage of the molecule into a fragment (A) which is capable of being 
incorporated into the complex and a fragment (B) which is inert. It is empha- 
sized that so far no direct evidence has been obtained for the existence of the 
B fragment. By inference, however, its size is estimated to be roughly half that 
of the A fragment, or one-third of the size of the native C'2 molecule. H.  J.  MOLLER-EBERHARD,  M.  )'.  POLLEY,  M.  A.  CALCOTT  377 
C'3 convertase is a labile enzyme, which decays at 32°C with a half-life  of 
approximately 12 mln.  However, its stability and also its activity are much 
increased when iodine-treated C'2 is used for the assembly of the enzyme. A 
similar  enhancing  effect of iodine has been described for the esterase activity 
of carboxypeptidase A (19). In the latter case, it is due to iodination, while the 
effect on C~2 appears  to be due to oxidation  (5).  How oxidation of Ct2  can 
affect the stability of the complex is presently not understood. 
Pertinent  in this connection are the observations made by Mayer and his 
associates who studied the behavior of guinea pig C'2 in immune hemolysis 
(20, 21). According to these authors, C'2 is reversibly adsorbed to EAC'4 cells; 
adsorption being favored by increase  of pH and temperature, and by decrease 
C'4i  [Monomei) 
(M=229,000) 
C'1 Esterasn 
N 
C'1 Esterase-  inactive  Activated  C'3 ¢oavertase  Inactive 
C'2 Complex  B FraEment  A Fragment  t/2  (32°Cj:T2 rain  A Frazmeat 
(M=39,000)  [M=76,000)  (M=305,000) 
FIG. 1S.  Postulated mechanism of formation of C'3 convertase. 
Native C'2 
IM=115,OOO) 
of ionic strength. These findings are in agreement with, and are fully explained 
by, the above demonstration  of the ability of C'2  and  C'4 to interact  with 
each other in free solution and to form reversible complexes. Mayer and asso- 
ciates also found that upon decay of EAC'la,4,2a to EAC'la,4, hemolytically 
inactive C'2 is released which can be detected by an immunochemical method. 
The molecular weight of the released C'2 was estimated to be 81,000, that of 
native  guinea  pig  C'2  130,000. The  size  difference  led  Mayer  to  postulate 
cleavage of C'2 upon fixation  during immune hemolysis,  a view which is com- 
patible with the data presented in this paper.  Borsos and Rapp  (22),  using 
only the  gel filtration  method,  reported  the  molecular weight  of C~2  to be 
150,000,  a  value  which  is probably  too  high  and  indicative  of  C'2-C'4 
interaction during measurement. 
Regarding the functional significance of C'3 convertase, four pertinent facts 
may be pointed out.  (a)  When  antibody and  complement attack  a  cell  the 
enzyme is assembled on the cell surface where it catalyzes binding of C~3 to 
the cell (1).  (b) In addition, it also governs the next reaction step, as the fifth, 
sixth,  and seventh components cannot act on the cell in the absence of C'3 
convertase  (18).  (c)  As demonstrated above, the enzyme, in its free form, is 378  MOLECULAR  COMPLEX  :FRO]~  HUMAN  COMPLEMENTS 
capable of triggering lysis of cells from the fluid phase. Although it is an in- 
efficient process, definite cell damage can be caused by this mechanism. It is 
conceivable that  this  mode  of action  of complement is  operative in  certain 
situations  in  vivo.  In  fact,  Yachnin  (23)  has  postulated  that  intravascular 
hemolysis in patients with paroxysmal nocturnal hemoglobinuria is  triggered 
by a  "fluid phase" reaction. (d) Finally, it is now becoming apparent that C'3 
convertase cleaves the  C'3  molecule yielding a  split product which,  through 
weak forces, remains attached to the parent molecule unless the pH is shifted 
toward acidity. The possibility is raised  that  the low molecular weight split 
product has biological activity. Dias da Silva and Lepow (24) have shown that 
anaphylatoxin has a molecular weight of less than 60,000 and that C'3 is prob- 
ably the donor of this histamine-releasing substance. The biological activities 
of various C'3 fragments are presently under investigation in this laboratory 
and it will be shown in a subsequent publication that certain pieces of the C'3 
molecule effect histamine release from mast cells and attraction of leukocytes.  4 
SUMMARY 
A functional unit of the human complement system has been delineated. It 
is composed of two subunits which are derived from the second (C'2) and from 
the fourth (C'4) component of complement. Purified C'2 and C'4 were found 
to interact in free solution and to form a  reversible protein-protein complex. 
When acted upon by C'I  esterase in the presence of Mg ions,  the reversible 
complex acquires stability and the  ability to act enzymatically on the  third 
component of complement. The trivial name C'3 convertase has been selected 
to denote the enzyme. Molecular weight determinations suggest that the entire 
C'4 molecule, but probably only a  fragment of the  Cr2  molecule, are incor- 
porated  into  C'3  convertase.  Prior treatment  of  C'2  with  iodine  led  to  en- 
hanced stability and activity of the enzyme. It was shown that the cell-bound 
form of C'3 convertase is cytolytically active and that the free enzyme is able 
to induce lysis from the fluid phase of erythrocytes from patients with paroxys- 
mal  nocturnal  hemoglobinuria.  Evidence  was  presented  that  action  of  C'3 
convertase on C'3 results in fragmentation of the molecule. 
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